Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis

Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis Shoichiro Tanaka , MD 1 2 , Tetsuro Kobayashi , MD 1 2 , Koji Nakanishi , MD 1 2 , Minoru Okubo , MD 1 2 , Toshio Murase , MD 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2001-09, Vol.24 (9), p.1661-1667
Hauptverfasser: TANAKA, Shoichiro, KOBAYASHI, Tetsuro, KOSUGE, Tomoo, SAKAMOTO, Michiie, TAKEUCHI, Kazuo, NAKANISHI, Koji, OKUBO, Minoru, MURASE, Toshio, HASHIMOTO, Masaji, WATANABE, Goro, MATSUSHITA, Hiroshi, ENDO, Yuzo, YOSHIZAKI, Hideo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Evidence of Primary β-Cell Destruction by T-Cells and β-Cell Differentiation From Pancreatic Ductal Cells in Diabetes Associated With Active Autoimmune Chronic Pancreatitis Shoichiro Tanaka , MD 1 2 , Tetsuro Kobayashi , MD 1 2 , Koji Nakanishi , MD 1 2 , Minoru Okubo , MD 1 2 , Toshio Murase , MD 1 2 , Masaji Hashimoto , MD 2 3 , Goro Watanabe , MD 2 3 , Hiroshi Matsushita , MD 2 4 , Yuzo Endo , MD 2 5 , Hideo Yoshizaki , MD 6 , Tomoo Kosuge , MD 7 , Michiie Sakamoto , MD 8 and Kazuo Takeuchi , MD 2 6 1 Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo 2 Okinaka Memorial Institute for Medical Research, Tokyo; the Departments of 3 Surgery 4 Pathology 5 Immunology, and 6 Gastroenterology, Toranomon Hospital, Tokyo 7 Department of Surgery and the 8 Division of Pathology, National Cancer Center, Tokyo, Japan Abstract OBJECTIVE —Diabetes associated with autoimmune chronic pancreatitis (ACP) is a subtype of diabetes that is responsive to corticosteroid treatment of progressive endocrine and exocrine dysfunction. However, little is known about pathological changes of islet and exocrine pancreas in ACP. RESEARCH DESIGN AND METHODS —We examined pancreatic specimens obtained on biopsy from four diabetic men with ACP (mean [range]: age 62 years [48–78], duration of ACP 3 months [1–5], duration of diabetes 1 month [0–3]) morphologically, immunohistochemically, and morphometrically. RESULTS —The pancreatic specimens in all cases exhibited inflammatory cell infiltration surrounding ductal cells and extensive fibrosis. Some islets were infiltrated with mononuclear cells with disrupted β-cells. The subsets of T-cells infiltrated to the islets were mainly CD8 + . Islet β-cell volume was decreased; the mean percentage area of β-cells in the islets in four cases with ACP were 16% (range 13–20) ( P = 0.0015 vs. type 2 diabetic patients, 48% [27–73], n = 8; P = 0.0002 vs. nondiabetic control subjects, 58% [39–77], n = 7). Preserved ductal cells were surrounded predominantly by CD8 + or CD4 + T-cells. Some cytokeratin 19–positive ductal cells contained insulin and glucagon, representing upregulated differentiation of islet cells from ductal cells. Insulin promoter factor-1 (IPF-1) was hyperexpressed in insulin-containing ductal cells. CONCLUSIONS —Diabetes associated with ACP is caused by T-cell–mediated mechanisms primarily involving islet β-cells as well as pancreatic ductal cells. In ACP, ductal islet precursor cells were associated with IPF-1 hyperexpre
ISSN:0149-5992
1935-5548
DOI:10.2337/diacare.24.9.1661